Scientists awarded £1m to help women make childbirth choices
Group will develop an aid that can be used to guide discussion between pregnant women
Read More
Author: John Pinching
ALTURiX Acquires UK rights to desmopressin oral solution
Deal is part of mission to increase options available prescribers, patients and the NHS
Read More
FlyPharma Conference Europe 2022 shares the latest supply chain challenges and advice for better industry collaboration
On 20-21 September 2022, the FlyPharma Conference Europe made a welcome return as a live, in-person event
Read More
Eli Lilly receives marketing authorisation for baricitinib
Treatment involves adult patients with severe alopecia areata
Read More
‘Junk’ DNA may hold the key to neurological disorders
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
